Friday, 31 July 2015

#GlenmarkPharma: #EarningsReport: Cons PAT at Rs 190 cr vs Rs 180 cr, up 5.6% YoY|Cons net sales at Rs 1,640 cr vs Rs 1,480 cr, up 10.8% YoY
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)